May-09-24 10:57PM
|
|
05:15PM
|
|
04:17PM
|
(Associated Press Finance) |
04:01PM
|
|
May-03-24 04:01PM
|
|
04:01PM |
Loading… |
Apr-05-24 04:01PM
|
|
Mar-28-24 01:53PM
|
|
09:40AM
|
|
08:40AM
|
(Associated Press Finance) |
08:30AM
|
|
Feb-29-24 09:05AM
|
|
Feb-28-24 04:30PM
|
|
Feb-14-24 09:00AM
|
|
Jan-31-24 06:30PM
|
|
Jan-11-24 01:26AM
|
|
01:26AM |
Loading… |
01:26AM
|
|
Jan-08-24 09:00AM
|
|
08:00AM
|
|
Jan-04-24 04:01PM
|
|
Dec-20-23 04:01PM
|
|
Dec-11-23 12:00PM
|
|
Dec-01-23 04:01PM
|
|
Nov-29-23 06:05PM
|
|
Nov-24-23 12:29PM
|
|
Nov-22-23 04:01PM
|
|
09:14AM
|
|
Nov-10-23 04:01PM
|
|
Nov-09-23 08:23AM
|
|
06:40AM
|
|
Nov-08-23 05:35PM
|
|
12:50PM |
Loading… |
Nov-05-23 12:50PM
|
|
Nov-02-23 05:42AM
|
|
02:25AM
|
(Thomson Reuters StreetEvents) |
Nov-01-23 08:35AM
|
(Associated Press Finance) |
08:30AM
|
|
Oct-06-23 04:01PM
|
|
Sep-21-23 09:19AM
|
|
Sep-19-23 04:01PM
|
|
Sep-01-23 04:01PM
|
|
Aug-31-23 04:01PM
|
|
Aug-13-23 10:44AM
|
|
Aug-08-23 05:30PM
|
|
04:18PM
|
|
04:01PM
|
|
Aug-04-23 04:01PM
|
|
Aug-01-23 04:01PM
|
|
Jul-31-23 04:01PM
|
|
Jul-29-23 11:07AM
|
|
Jul-17-23 07:29AM
|
|
Jul-07-23 04:01PM
|
|
Jun-16-23 06:05AM
|
|
Jun-07-23 04:01PM
|
|
Jun-05-23 09:00AM
|
|
Jun-02-23 04:01PM
|
|
May-18-23 07:09AM
|
|
May-08-23 05:15PM
|
|
04:12PM
|
|
04:01PM
|
|
May-07-23 08:59AM
|
|
May-05-23 04:01PM
|
|
May-01-23 04:01PM
|
|
Apr-16-23 12:08PM
|
|
Mar-31-23 04:01PM
|
|
Mar-24-23 09:35AM
|
|
Mar-03-23 04:01PM
|
|
09:40AM
|
|
Mar-01-23 04:01PM
|
|
Feb-21-23 04:01PM
|
|
Feb-15-23 06:58AM
|
|
Feb-08-23 05:15PM
|
|
04:01PM
|
|
06:00AM
|
|
Feb-06-23 08:00AM
|
|
Feb-03-23 04:01PM
|
|
Jan-13-23 04:01PM
|
|
Jan-04-23 04:01PM
|
|
Dec-24-22 10:07AM
|
|
Dec-20-22 04:33PM
|
|
Dec-19-22 08:00AM
|
|
07:00AM
|
|
Dec-15-22 04:01PM
|
|
Dec-12-22 10:00AM
|
|
Dec-02-22 04:01PM
|
|
Nov-23-22 08:00AM
|
|
Nov-22-22 05:03AM
|
|
Nov-10-22 05:52AM
|
(Simply Wall St.) +23.97% |
Nov-09-22 04:01PM
|
|
Nov-08-22 05:15PM
|
|
04:01PM
|
|
Nov-04-22 04:01PM
|
|
Nov-01-22 04:05PM
|
|
Oct-26-22 02:01AM
|
|
Oct-14-22 07:08AM
|
|
Oct-13-22 12:51PM
|
|
Oct-10-22 04:01PM
|
|
Oct-07-22 10:01AM
|
|
Oct-06-22 01:36PM
|
|
Sep-30-22 08:59AM
|
|
Sep-29-22 11:09AM
|
|
07:30AM
|
|
|
|
|
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Touchon Pascal | President and CEO | Mar 04 '24 | Sale | 0.72 | 24,844 | 17,888 | 1,910,652 | Mar 06 06:19 PM | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Mar 04 '24 | Sale | 0.72 | 10,746 | 7,737 | 941,397 | Mar 06 06:18 PM | Murugan Amar | EVP, Chief Legal Officer | Mar 04 '24 | Sale | 0.72 | 10,044 | 7,232 | 727,521 | Mar 06 06:18 PM | Henrich Jill | EVP, Global Head RA & Quality | Mar 04 '24 | Sale | 0.72 | 3,879 | 2,793 | 555,001 | Mar 06 06:16 PM | Touchon Pascal | President and CEO | Nov 16 '23 | Sale | 0.39 | 20,409 | 7,939 | 655,496 | Nov 20 05:31 PM | Joshi Manher | EVP, Chief Medical Officer | Nov 16 '23 | Sale | 0.39 | 12,287 | 4,780 | 171,284 | Nov 20 05:30 PM | Hyllengren Eric J | SVP, CFO | Nov 16 '23 | Sale | 0.39 | 11,958 | 4,652 | 205,998 | Nov 20 05:29 PM | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Nov 16 '23 | Sale | 0.39 | 8,856 | 3,445 | 277,143 | Nov 20 05:31 PM | Murugan Amar | EVP, Chief Legal Officer | Nov 16 '23 | Sale | 0.39 | 8,307 | 3,231 | 257,084 | Nov 20 05:30 PM | Henrich Jill | EVP, Global Head RA & Quality | Nov 16 '23 | Sale | 0.39 | 3,267 | 1,271 | 104,424 | Nov 20 05:29 PM | Gallagher Carol Giltner | Director | Nov 14 '23 | Buy | 0.31 | 90,980 | 28,186 | 459,418 | Nov 15 05:07 PM | Gallagher Carol Giltner | Director | Nov 13 '23 | Buy | 0.22 | 179,020 | 40,029 | 368,438 | Nov 15 05:07 PM | DOBMEIER ERIC | Director | Nov 10 '23 | Buy | 0.23 | 446,825 | 101,340 | 563,325 | Nov 14 06:27 PM | HEIDEN WILLIAM K | Director | Nov 10 '23 | Buy | 0.25 | 100,000 | 25,330 | 209,000 | Nov 14 06:29 PM | Touchon Pascal | President and CEO | Aug 16 '23 | Sale | 1.65 | 30,766 | 50,835 | 675,905 | Aug 18 06:25 PM | Nguyen AnhCo | EVP, Chief Sci. & Tech Officer | Aug 16 '23 | Sale | 1.65 | 15,126 | 24,997 | 285,999 | Aug 18 06:25 PM | Murugan Amar | EVP, Chief Legal Officer | Aug 16 '23 | Sale | 1.65 | 8,672 | 14,330 | 265,391 | Aug 18 06:25 PM | Hyllengren Eric J | SVP, CFO | Aug 16 '23 | Sale | 1.65 | 8,186 | 13,527 | 217,956 | Aug 18 06:25 PM | Joshi Manher | EVP, Chief Medical Officer | Aug 16 '23 | Sale | 1.65 | 6,975 | 11,526 | 183,571 | Aug 18 06:25 PM | Henrich Jill | EVP, Global Head RA & Quality | Aug 16 '23 | Sale | 1.65 | 3,346 | 5,531 | 107,691 | Aug 18 06:25 PM | Touchon Pascal | President and CEO | Jun 27 '23 | Sale | 1.66 | 14,291 | 23,723 | 706,671 | Jun 29 04:15 PM |
|